The purpose of this study is to investigate risk factors, screening tools and intervention methods that could help provide early diagnosis or prevention of uterine cancer. The study will evaluate how or if these screening and intervention methods are understood, accepted and completed by postmenopausal participants. The ultimate goal is to identify people at high risk for developing endometrial (uterine) cancer through various screening techniques and then tailor an approach to reduce risk through a program of lifestyle interventions.
Closed for Recruitment
The purpose of this study is to test whether an oral micronized progesterone reduces the score, number and severity of hot flushes and night sweats in perimenopausal women. Oral micronized progesterone is molecularly identical to human progesterone, a steroid hormone. It is sold by prescription for use to prevent endometrial cancer in women taking estrogen in menopause. This research study will test whether progesterone reduces perimenopausal hot flushes and night sweats. It will also test whether progesterone improves sleep disturbances and anxiety.